Found vs Henry Meds 2026: GLP-1 Pricing, Plans, and Availability

Last reviewed: August 31, 2026 Last updated: August 31, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

PlexusDx publishes this comparison and is one of the providers discussed. We use the same evidence rules for our own program and competing programs.

The short answer

These two programs are less interchangeable than their sticker prices suggest. Found bills its monthly plan every 4 weeks — 13 charges in a calendar year — so its $289 semaglutide "monthly" rate costs about $3,757 a year, more than Henry's $297 calendar-month plan at $3,564. Flip to long commitments and the order reverses: Found's 12-month plan at $169/month works out to about $2,028, well under Henry's $2,364 paid-in-full year. Medication lineups differ sharply too: Found is injection-only but carries injectable tirzepatide, which Henry does not offer at all; Henry counters with oral and microdose options Found lacks.

At a glance

The billing-clock problem, normalized

Found's monthly plan renews every 4 weeks, which produces 13 charges across 52 weeks. Henry bills by calendar month. To compare them honestly, annualize both. All per-month equivalents below are our calculations from each program's charged amounts.

Two honest observations from that table. On flexible billing, Henry's higher sticker ($297 vs $289) is actually the cheaper year because of the billing clock. On committed plans, Found's $2,028 undercuts Henry's $2,364 — and Found's cash ladder is genuine volume tiering, with 3-month ($249/mo), 6-month ($219/mo), and 12-month ($169/mo) steps, billed per cycle rather than demanded upfront in full. Henry's discounted year requires the full $2,364 at once. Both are beaten on flexibility economics by a calendar-month plan at a lower rate: PlexusDx's $189 month-to-month costs $2,268 with no commitment at all — $1,489 less than Found's flexible year and $1,296 less than Henry's.

Found also runs a separate insurance track (plans from $99/month with insurance on its longest term, and monthly insurance plans from $199) — if your coverage qualifies, that changes the math entirely and is worth checking first. Insurance pricing is never directly comparable to cash pricing, so we keep the two apart.

Cancellation and commitment risk

Found states a 100% refund if you are not clinically eligible, allows cancellation in its app at any time, and notes that medications, lab kits, co-pays, and processed renewal payments are non-refundable. Henry's terms commit you to the full contract term if prescribed: its own FAQ states that on a multi-month plan you may be required to pay out the rest of your balance unless a provider approves a medical reason. Read both policies before choosing a term plan — the discount is real, but so is the obligation.

Choose Found if…

You want injectable tirzepatide (Henry doesn't carry it), you value a genuine term-discount ladder billed per cycle instead of paid upfront, or you may qualify for its insurance track. Its flat dose pricing and 24/7 chat coaching round out a strong long-commitment cash offer.

Choose Henry Meds if…

You want oral or microdose options, prefer calendar-month billing with no 4-week clock, or want the flexible-monthly path at the lower true annual cost of the two. Its $0-until-prescribed checkout is also a low-risk way to find out whether you qualify.

Where PlexusDx fits

PlexusDx publishes every rate before checkout and charges calendar-monthly with no membership fee: semaglutide injection $189/month, tirzepatide injection $289/month, oral options, and a $129/month flat microdose protocol — with optional 3- and 6-month rates ($169/$149 on semaglutide) rather than mandatory prepayment. See current pricing on the Semaglutide Injection and Tirzepatide Injection pages.

Methodology and freshness

Found figures come from PlexusDx's documented capture of Found's signup funnel and payment page on July 20, 2026, published on PlexusDx vs Found; Found's public pricing page re-confirmed the $289 monthly and $169/month 12-month cash rates on August 31, 2026. Henry Meds figures come from Henry's published program pages and a signup run to the order summary on July 20, 2026 (27 dated screenshots), published on PlexusDx vs Henry Meds; Henry's public pages re-confirmed its included-services and cancellation language on August 31, 2026. PlexusDx rates were verified on our live product pages on August 31, 2026. Annualizations are our calculations from charged amounts. Our full provider index lives on the GLP-1 alternatives hub.

Frequently Asked Questions

Is Found or Henry Meds cheaper for semaglutide?

It depends on commitment. On flexible plans, Henry's $297 calendar-month billing totals $3,564 a year versus about $3,757 for Found's $289-every-4-weeks plan. On the longest cash commitments, Found's 12-month plan at $169/month (about $2,028) beats Henry's $2,364 paid-in-full year. Neither flexible plan beats a lower calendar-month rate like PlexusDx's $189.

Does Henry Meds offer injectable tirzepatide?

No. In our July 2026 capture, Henry offered injectable semaglutide, oral and microdose semaglutide options, an oral tirzepatide dissolving tablet, liraglutide, and phentermine — but no injectable tirzepatide. Patients set on injectable tirzepatide would need Found ($359 every 4 weeks), PlexusDx ($289/month), or another provider.

Why does Found's monthly plan cost more per year than its sticker price suggests?

Found's monthly plan renews every 4 weeks rather than every calendar month, producing 13 charges across a 52-week year. At $289 per charge that is roughly $3,757 annually — about $289 more than a true calendar-month plan at the same sticker would cost. Found's multi-month plans bill on longer cycles, which softens this effect on its term plans.

Do Found or Henry Meds charge membership fees?

Neither program showed a separate membership or platform fee in our captures: both bundle the provider access, medication, and shipping into the plan price. The structural differences are the billing clock, the prepayment requirements on Henry's discounted terms, and Found's separate insurance track.

What should transfer or maintenance patients check first?

Availability, then commitment terms. Found is injection-only with no maintenance tier, while Henry offers microdose and oral options but applies payout obligations to multi-month plans. Patients stepping down after reaching goal weight should compare dedicated maintenance protocols and month-to-month flexibility before committing to a term.

Sources

• PlexusDx vs Found — checkout-verified comparison (captured July 20, 2026)
• PlexusDx vs Henry Meds — checkout-verified comparison (captured July 20, 2026)
• Found public pricing pages, joinfound.com (accessed August 31, 2026)
• Henry Meds public treatment pages, henrymeds.com (accessed August 31, 2026)
• PlexusDx Semaglutide Injection and Tirzepatide Injection (accessed August 31, 2026)
• PlexusDx GLP-1 alternatives hub — methodology and provider index

Compounded medication disclosure: Compounded medications are not FDA-approved. FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. A licensed clinician determines whether a prescription is appropriate for an individual patient. PlexusDx works with licensed 503A compounding pharmacies. Eligibility, medication choice, dose, and ongoing treatment decisions are made by a licensed clinician based on the patient's medical history and clinical circumstances.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.